Summary
This prediction ended on 26.02.24 with a price of €28.69. Massive losses of -51.27% were the result for the BUY prediction by Biggybaer. Biggybaer has a follow-up prediction for Bayer AG where he still thinks Bayer AG is a Buy. Dividends of €2.55 are taken into consideration when calculating the performance. This prediction was marked as speculative and is excluded from Biggybaer's performance statistics.Bayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bayer AG | -3.255% | -3.255% | 84.817% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by Biggybaer for this prediction
In the thread Bayer AG diskutieren
Buy mit Kursziel 65,0
In the thread Trading Bayer AG
Die von Biggybaer gewählte maximale Laufzeit wurde überschritten